Markets.com Logo

FATE

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.1181$
  • Previous Close
    1.1181$
  • 52 Week Change
    3.54$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.6611$ - 4.2$
  • Dividend Per Share
    --
  • Market cap
    128 M$
  • EPS
    -0.29
  • Beta
    2.245
  • Volume
    --

About

FATE.US represents Fate Therapeutics Inc., a biopharmaceutical company focused on the development of cell-based immunotherapies for cancer and immune disorders. The ".US" suffix indicates that the stock is traded on a United States stock exchange. Fate Therapeutics utilizes its induced pluripotent stem cell (iPSC) platform to generate engineered immune cell products, including natural killer (NK) cells and T cells, aiming to provide off-the-shelf, readily available therapies for patients. The company's pipeline includes several clinical-stage programs evaluating its cell therapy candidates in various cancer types.
Forex Market Analysis: What Factors Are Influencing the GBP/AED Exchange Rate in 2026?

Forex Market Analysis: What Factors Are Influencing the GBP/AED Exchange Rate in 2026?

Frances Wang|--
Commodity market today: UAE to exit OPEC on May 1, how will this impact global oil prices?

Commodity market today: UAE to exit OPEC on May 1, how will this impact global oil prices?

Frances Wang|--
Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?

Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?

Ghko B|--
Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders

Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders

Ghko B|--
ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

Ghko B|--
Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Ghko B|--

Oil Market Paradox: Geopolitical Tensions vs. Stable Prices

Ava Grace|--

Factors

Clinical Trial Results: Positive data boosts investor confidence; negative results can lead to significant price drops.

Regulatory Approval: FDA approval for Fate Therapeutics' cell therapies greatly impacts stock value.

Partnerships & Collaborations: Alliances with larger pharmaceutical companies can drive growth and stock price.

Market Sentiment: Overall investor attitude towards biotechnology and cell therapy affects FATE's valuation.

Financial Performance: Revenue, expenses, and cash flow impact investor perception of the company's long-term viability.

Competition: Advancements and approvals from competitors in the cell therapy space can put downward pressure on FATE's stock.

People Also Watch

Latest news

Forex Market Today: USD/JPY Surges Above 150 as Dollar Strength Returns Amid Fed Rate Outlook

Forex Market Today: USD/JPY Surges Above 150 as Dollar Strength Returns Amid Fed Rate Outlook

Ghko B|--
Q1 2026 Earnings to Watch Today: Coca-Cola (KO) Set to Report Before Market Open

Q1 2026 Earnings to Watch Today: Coca-Cola (KO) Set to Report Before Market Open

Frances Wang|--
Gold Price Today, May 06: XAU/USD Hits Fresh Highs Above $4,600 as Safe-Haven Demand Surges Amid Global Uncertainty

Gold Price Today, May 06: XAU/USD Hits Fresh Highs Above $4,600 as Safe-Haven Demand Surges Amid Global Uncertainty

Ghko B|--

Latest Education Articles

Scalping vs Day Trading: Key Differences, Strategies and Risks

Scalping vs Day Trading: Key Differences, Strategies and Risks

Julian Parker|--
What Is Scalping in Trading? A Practical Guide for CFD Traders

What Is Scalping in Trading? A Practical Guide for CFD Traders

Julian Parker|--
Copy Trading vs Mirror Trading: Key Differences, Risks and Which One Suits CFD Traders?

Copy Trading vs Mirror Trading: Key Differences, Risks and Which One Suits CFD Traders?

Julian Parker|--
Recommended Topics